This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Hassan Javanbakht in Immunology
Introduction
Hassan Javanbakht is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly through his innovative work on interleukin-2 variant proteins.
Latest Patents
Hassan Javanbakht holds a patent for "Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereof." This patent describes serum half-life extended-IL-2 variant (IL-2v) heterodimers that exhibit reduced binding to the IL2Rα (CD25) subunit. The Fc-IL-2v heterodimers provided in this patent are designed for enhancing immune responses, particularly in the prevention and treatment of viral infections and cancer.
Career Highlights
Hassan is currently employed at Gilead Sciences, Inc., where he continues to advance his research and development efforts in immunotherapy. His work has the potential to significantly impact the treatment of various diseases.
Collaborations
Hassan collaborates with talented individuals such as Manuel Baca and Sarah A. Gilmore, contributing to a dynamic research environment.
Conclusion
Hassan Javanbakht's innovative work in the field of immunology exemplifies the importance of research in developing new therapeutic strategies. His contributions are paving the way for advancements in the treatment of viral infections and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile